Population
Sera from patients with chronic hepatitis C (including two patients analyzed for antibody kinetics)
Design
Preclinical
Follow-up
several months
Authors
Loading...
Sequence-specific anti-HVR1 immunity may drive HCV evolution; leaves open human translation and therapeutic targeting.
Anti-HVR1 antibodies are sequence-specific and appear to be involved in the genetic drift of HVR1 by immunoselection in chronic HCV infection.
Kato et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: